Functional food support! Introducing features that reduce transient fatigue and daytime drowsiness.
We would like to introduce the effects of our black soybean polyphenol product "Chronocare" on improving sleep quality. After 12 weeks of taking this product, results showed a reduction in morning drowsiness. EEG tests indicated improvements in falling asleep, an increase in total sleep time for women, and an increase in deep sleep for those with poor sleep quality. Additionally, improvements in vascular function, such as vascular age and the number of capillaries, as well as enhancements in cold sensitivity (skin surface temperature) and evening leg swelling, have also been confirmed. 【Functions】 ■ Improvement of "sleep quality" ■ Improvement of vascular function (vascular age, capillaries) ■ Improvement of cold sensitivity (skin surface temperature) ■ Improvement of swelling *For more details, please download the PDF or feel free to contact us.
Inquire About This Product
basic information
For more details, please download the PDF or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please download the PDF or feel free to contact us.
catalog（2）
Download All Catalogs
Company information
Fujikko Co., Ltd. is a company engaged in the manufacturing and sales of various food products. Starting with "kombu" at its inception, it has expanded its business to include "beans," "desserts," and "yogurt," while always being mindful of health and deliciousness. The company is committed to the quality of ingredients, additive-free preservation techniques, and the pursuit of food safety and security. Furthermore, Japan is now said to be a country with a high prevalence of lifestyle-related diseases, but we are confident that the health benefits of soy isoflavones, black soybean polyphenols, dietary fiber and minerals from kombu, and lactic acid bacteria from Caspian Sea yogurt, which we have clarified through our foundational research, will contribute to the prevention of lifestyle-related diseases in the future.